CURE Pharmaceutical [OTCQB:CURR] to Present at the 12th Annual LD Micro Main Event Investor Conference
December 05, 2019 07:00 ET
|
Cure Pharmaceutical Holding Corp.
LOS ANGELES, Dec. 05, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 12th Annual LD...
CURE Pharmaceutical to Present at the 9th Annual LD Micro Invitational
May 30, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
LOS ANGELES, May 30, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 9th Annual LD...
CURE Pharmaceutical Extends Closing Of Privately-Held Chemistry Holdings Inc. Acquisition to May 13
May 01, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, today announced that it has extended the close of the...
Cure Pharmaceutical [OTCQB:CURR] to Present at the “Planet MicroCap Showcase 2019”
April 30, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
LAS VEGAS, April 30, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at the Planet MicroCap...
CURE Pharmaceutical to Acquire Privately-Held Chemistry Holdings Inc., Expanding Its Technology Platform in Oral Drug Delivery
April 01, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., April 01, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, today announced that it has agreed to acquire...
National Healthcare Economics and Policy Expert Ruben Jose King-Shaw Jr Joins CURE Pharmaceutical’s Board of Directors
January 29, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced Ruben Jose King-Shaw Jr. has joined its Board...
CURE Pharmaceutical To Present at Benzinga Cannabis Capital Conference
January 09, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
LOS ANGELES, Jan. 09, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will host an investor presentation at the...
Prominent Biotech Investor Gene Salkind Adds Another $2M Investment in CURE Pharmaceutical
November 01, 2018 07:25 ET
|
CURE Pharmaceutical
OXNARD, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, has announced that the company secured a $2 million investment...
CURE Pharmaceutical to Present at The MicroCap Conference on October 1st and 2nd in New York City at the Essex House
September 28, 2018 07:25 ET
|
CURE Pharmaceutical
NEW YORK, Sept. 28, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, will be presenting at this year's MicroCap Conference on October...
CURE Pharmaceutical Expands Distribution of CUREfilm Technology with First Licensing Agreement
September 05, 2018 08:57 ET
|
CURE Pharmaceutical
LOS ANGELES, Sept. 05, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), (“CURE”), an innovative drug delivery and development company, today announced that it entered into a multi-year...